JP6817966B2 - 高アンモニア血症に関連する疾患を治療するために操作された細菌 - Google Patents

Info

Publication number

JP6817966B2

JP6817966B2 JP2017564379A JP2017564379A JP6817966B2 JP 6817966 B2 JP6817966 B2 JP 6817966B2 JP 2017564379 A JP2017564379 A JP 2017564379A JP 2017564379 A JP2017564379 A JP 2017564379A JP 6817966 B2 JP6817966 B2 JP 6817966B2

Authority

JP

Japan

Prior art keywords

arginine

promoter

genetically engineered

gene

bacterium

Prior art date

2015-06-10

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired - Fee Related

Links

• Espacenet
• Global Dossier
• Discuss

• 241000894006 Bacteria Species 0.000 title claims description 287
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims description 51
• 206010020575 Hyperammonaemia Diseases 0.000 title claims description 49
• 201000010099 disease Diseases 0.000 title claims description 17
• 239000004475 Arginine Substances 0.000 claims description 274
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 273
• 108090000623 proteins and genes Proteins 0.000 claims description 272
• FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 182
• XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 96
• 230000001105 regulatory effect Effects 0.000 claims description 81
• 230000014509 gene expression Effects 0.000 claims description 80
• 102000004190 Enzymes Human genes 0.000 claims description 61
• 108090000790 Enzymes Proteins 0.000 claims description 61
• 229940088598 enzyme Drugs 0.000 claims description 61
• 102000004169 proteins and genes Human genes 0.000 claims description 54
• 230000001580 bacterial effect Effects 0.000 claims description 51
• 230000006696 biosynthetic metabolic pathway Effects 0.000 claims description 51
• 241000588724 Escherichia coli Species 0.000 claims description 48
• 235000019260 propionic acid Nutrition 0.000 claims description 48
• IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 48
• 208000007386 hepatic encephalopathy Diseases 0.000 claims description 41
• 239000013612 plasmid Substances 0.000 claims description 41
• 210000001035 gastrointestinal tract Anatomy 0.000 claims description 40
• 108010032178 Amino-acid N-acetyltransferase Proteins 0.000 claims description 37
• 102000007610 Amino-acid N-acetyltransferase Human genes 0.000 claims description 37
• 208000035475 disorder Diseases 0.000 claims description 34
• 210000000349 chromosome Anatomy 0.000 claims description 32
• 230000007613 environmental effect Effects 0.000 claims description 27
• 208000028547 Inborn Urea Cycle disease Diseases 0.000 claims description 25
• 208000030954 urea cycle disease Diseases 0.000 claims description 25
• 230000005764 inhibitory process Effects 0.000 claims description 21
• 238000000034 method Methods 0.000 claims description 21
• 150000004666 short chain fatty acids Chemical class 0.000 claims description 20
• 102100028200 Ornithine transcarbamylase, mitochondrial Human genes 0.000 claims description 19
• 101150089004 argR gene Proteins 0.000 claims description 19
• 235000016709 nutrition Nutrition 0.000 claims description 18
• 206010021143 Hypoxia Diseases 0.000 claims description 16
• 238000012217 deletion Methods 0.000 claims description 16
• 230000037430 deletion Effects 0.000 claims description 16
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 15
• 239000004472 Lysine Substances 0.000 claims description 15
• 230000007812 deficiency Effects 0.000 claims description 15
• 239000002207 metabolite Substances 0.000 claims description 15
• 230000001146 hypoxic effect Effects 0.000 claims description 14
• 241000193403 Clostridium Species 0.000 claims description 12
• 239000000203 mixture Substances 0.000 claims description 12
• 235000021391 short chain fatty acids Nutrition 0.000 claims description 12
• 238000003780 insertion Methods 0.000 claims description 10
• 230000037431 insertion Effects 0.000 claims description 10
• 102000003960 Ligases Human genes 0.000 claims description 9
• 108090000364 Ligases Proteins 0.000 claims description 9
• 241000124008 Mammalia Species 0.000 claims description 9
• 210000000813 small intestine Anatomy 0.000 claims description 9
• 239000006041 probiotic Substances 0.000 claims description 8
• 235000018291 probiotics Nutrition 0.000 claims description 8
• 238000006467 substitution reaction Methods 0.000 claims description 8
• 241000186000 Bifidobacterium Species 0.000 claims description 7
• 239000002773 nucleotide Substances 0.000 claims description 7
• 125000003729 nucleotide group Chemical group 0.000 claims description 7
• 238000007254 oxidation reaction Methods 0.000 claims description 7
• 230000000529 probiotic effect Effects 0.000 claims description 7
• 239000007845 reactive nitrogen species Substances 0.000 claims description 7
• 239000003642 reactive oxygen metabolite Substances 0.000 claims description 7
• 238000002560 therapeutic procedure Methods 0.000 claims description 7
• 206010067125 Liver injury Diseases 0.000 claims description 6
• 230000000968 intestinal effect Effects 0.000 claims description 6
• 231100000331 toxic Toxicity 0.000 claims description 6
• 230000002588 toxic effect Effects 0.000 claims description 6
• 241000606125 Bacteroides Species 0.000 claims description 5
• 230000003647 oxidation Effects 0.000 claims description 5
• 239000000126 substance Substances 0.000 claims description 5
• GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 claims description 4
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 4
• GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 claims description 4
• PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 claims description 3
• 208000007788 Acute Liver Failure Diseases 0.000 claims description 3
• 206010000804 Acute hepatic failure Diseases 0.000 claims description 3
• 206010062695 Arginase deficiency Diseases 0.000 claims description 3
• 208000034318 Argininemia Diseases 0.000 claims description 3
• 206010058298 Argininosuccinate synthetase deficiency Diseases 0.000 claims description 3
• 201000011297 Citrullinemia Diseases 0.000 claims description 3
• 208000010334 End Stage Liver Disease Diseases 0.000 claims description 3
• 101000986595 Homo sapiens Ornithine transcarbamylase, mitochondrial Proteins 0.000 claims description 3
• 208000000599 Ornithine Carbamoyltransferase Deficiency Disease Diseases 0.000 claims description 3
• 206010052450 Ornithine transcarbamoylase deficiency Diseases 0.000 claims description 3
• 208000035903 Ornithine transcarbamylase deficiency Diseases 0.000 claims description 3
• 231100000836 acute liver failure Toxicity 0.000 claims description 3
• 201000003554 argininosuccinic aciduria Diseases 0.000 claims description 3
• 229960004203 carnitine Drugs 0.000 claims description 3
• 208000011444 chronic liver failure Diseases 0.000 claims description 3
• 231100000753 hepatic injury Toxicity 0.000 claims description 3
• 201000011286 hyperargininemia Diseases 0.000 claims description 3
• 208000015181 infectious disease Diseases 0.000 claims description 3
• 208000019423 liver disease Diseases 0.000 claims description 3
• 235000021048 nutrient requirements Nutrition 0.000 claims description 3
• 201000011278 ornithine carbamoyltransferase deficiency Diseases 0.000 claims description 3
• 108700005389 3-methylcrotonyl CoA carboxylase 1 deficiency Proteins 0.000 claims description 2
• 201000008000 3-methylcrotonyl-CoA carboxylase deficiency Diseases 0.000 claims description 2
• 108010024976 Asparaginase Proteins 0.000 claims description 2
• 102000015790 Asparaginase Human genes 0.000 claims description 2
• 206010058297 Carbamoyl phosphate synthetase deficiency Diseases 0.000 claims description 2
• 208000033910 Carbamoyl-phosphate synthetase 1 deficiency Diseases 0.000 claims description 2
• 208000007698 Gyrate Atrophy Diseases 0.000 claims description 2
• 208000034596 Gyrate atrophy of choroid and retina Diseases 0.000 claims description 2
• 208000000420 Isovaleric acidemia Diseases 0.000 claims description 2
• 208000034578 Multiple myelomas Diseases 0.000 claims description 2
• 208000000693 Neurogenic Urinary Bladder Diseases 0.000 claims description 2
• 206010029279 Neurogenic bladder Diseases 0.000 claims description 2
• 208000012868 Overgrowth Diseases 0.000 claims description 2
• 206010035226 Plasma cell myeloma Diseases 0.000 claims description 2
• 208000021886 Pyruvate carboxylase deficiency Diseases 0.000 claims description 2
• 229960003272 asparaginase Drugs 0.000 claims description 2
• DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 claims description 2
• 238000010322 bone marrow transplantation Methods 0.000 claims description 2
• 208000022843 carbamoyl phosphate synthetase I deficiency disease Diseases 0.000 claims description 2
• 239000001569 carbon dioxide Substances 0.000 claims description 2
• 229910002092 carbon dioxide Inorganic materials 0.000 claims description 2
• 238000002512 chemotherapy Methods 0.000 claims description 2
• NIJJYAXOARWZEE-UHFFFAOYSA-N di-n-propyl-acetic acid Natural products CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 claims description 2
• 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
• 239000003937 drug carrier Substances 0.000 claims description 2
• 229930195729 fatty acid Natural products 0.000 claims description 2
• 239000000194 fatty acid Substances 0.000 claims description 2
• 150000004665 fatty acids Chemical class 0.000 claims description 2
• 208000012268 mitochondrial disease Diseases 0.000 claims description 2
• 230000035764 nutrition Effects 0.000 claims description 2
• 150000007524 organic acids Chemical class 0.000 claims description 2
• 208000014380 ornithine aminotransferase deficiency Diseases 0.000 claims description 2
• 201000004012 propionic acidemia Diseases 0.000 claims description 2
• 208000011580 syndromic disease Diseases 0.000 claims description 2
• MSRILKIQRXUYCT-UHFFFAOYSA-M valproate semisodium Chemical compound [Na+].CCCC(C(O)=O)CCC.CCCC(C([O-])=O)CCC MSRILKIQRXUYCT-UHFFFAOYSA-M 0.000 claims description 2
• 229960000604 valproic acid Drugs 0.000 claims description 2
• 241000194036 Lactococcus Species 0.000 claims 2
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims 2
• 206010059521 Methylmalonic aciduria Diseases 0.000 claims 1
• 230000018044 dehydration Effects 0.000 claims 1
• 238000006297 dehydration reaction Methods 0.000 claims 1
• 201000003694 methylmalonic acidemia Diseases 0.000 claims 1
• 238000000386 microscopy Methods 0.000 claims 1
• 230000002685 pulmonary effect Effects 0.000 claims 1
• NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical compound OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 claims 1
• 229960003040 rifaximin Drugs 0.000 claims 1
• 229940113082 thymine Drugs 0.000 claims 1
• 230000002485 urinary effect Effects 0.000 claims 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 290
• 229960003121 arginine Drugs 0.000 description 267
• 235000009697 arginine Nutrition 0.000 description 266
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 265
• 229910021529 ammonia Inorganic materials 0.000 description 145
• 101710149879 Arginine repressor Proteins 0.000 description 111
• ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 104
• 238000004519 manufacturing process Methods 0.000 description 89
• 230000027455 binding Effects 0.000 description 80
• 238000009739 binding Methods 0.000 description 80
• 108090000765 processed proteins & peptides Proteins 0.000 description 77
• 230000001851 biosynthetic effect Effects 0.000 description 76
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 65
• 230000015572 biosynthetic process Effects 0.000 description 59
• 101150072344 argA gene Proteins 0.000 description 57
• 235000018102 proteins Nutrition 0.000 description 53
• BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 50
• 102000004196 processed proteins & peptides Human genes 0.000 description 50
• 229960003692 gamma aminobutyric acid Drugs 0.000 description 48
• 210000004027 cell Anatomy 0.000 description 47
• 230000035772 mutation Effects 0.000 description 46
• 150000007523 nucleic acids Chemical group 0.000 description 46
• 230000001939 inductive effect Effects 0.000 description 43
• 229920001184 polypeptide Polymers 0.000 description 40
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 34
• RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 33
• RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 33
• 229960002173 citrulline Drugs 0.000 description 33
• 235000013477 citrulline Nutrition 0.000 description 33
• 102000039446 nucleic acids Human genes 0.000 description 33
• 108020004707 nucleic acids Proteins 0.000 description 33
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 32
• 239000011572 manganese Substances 0.000 description 32
• 239000001301 oxygen Substances 0.000 description 32
• 229910052760 oxygen Inorganic materials 0.000 description 32
• 108700020534 tetracycline resistance-encoding transposon repressor Proteins 0.000 description 32
• 101150118463 argG gene Proteins 0.000 description 31
• PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 30
• 229910052748 manganese Inorganic materials 0.000 description 30
• 239000006227 byproduct Substances 0.000 description 29
• FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 26
• 241000699670 Mus sp. Species 0.000 description 25
• 230000001965 increasing effect Effects 0.000 description 25
• 239000000543 intermediate Substances 0.000 description 25
• 230000001225 therapeutic effect Effects 0.000 description 25
• 244000005700 microbiome Species 0.000 description 23
• 230000009467 reduction Effects 0.000 description 23
• 238000006722 reduction reaction Methods 0.000 description 23
• 230000003248 secreting effect Effects 0.000 description 23
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 20
• MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 20
• 241000894007 species Species 0.000 description 20
• 108010078791 Carrier Proteins Proteins 0.000 description 19
• 235000001014 amino acid Nutrition 0.000 description 19
• PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 19
• PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 19
• SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 19
• 210000004369 blood Anatomy 0.000 description 19
• 239000008280 blood Substances 0.000 description 19
• 229910052757 nitrogen Inorganic materials 0.000 description 19
• BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 18
• 230000001147 anti-toxic effect Effects 0.000 description 18
• 239000003053 toxin Substances 0.000 description 18
• 101710113083 Carbamoyl-phosphate synthase Proteins 0.000 description 17
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 17
• 102000001253 Protein Kinase Human genes 0.000 description 17
• 125000003275 alpha amino acid group Chemical group 0.000 description 17
• 229940024606 amino acid Drugs 0.000 description 17
• 150000001413 amino acids Chemical class 0.000 description 17
• 230000035897 transcription Effects 0.000 description 17
• 238000013518 transcription Methods 0.000 description 17
• 238000011282 treatment Methods 0.000 description 17
• 102000004316 Oxidoreductases Human genes 0.000 description 16
• 108090000854 Oxidoreductases Proteins 0.000 description 16
• 229940023064 escherichia coli Drugs 0.000 description 16
• -1 for example Chemical compound 0.000 description 16
• 229960002743 glutamine Drugs 0.000 description 16
• 230000002829 reductive effect Effects 0.000 description 16
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 16
• 231100000765 toxin Toxicity 0.000 description 16
• 108700012359 toxins Proteins 0.000 description 16
• OJJHFKVRJCQKLN-YFKPBYRVSA-N (4s)-4-acetamido-5-oxo-5-phosphonooxypentanoic acid Chemical compound OC(=O)CC[C@H](NC(=O)C)C(=O)OP(O)(O)=O OJJHFKVRJCQKLN-YFKPBYRVSA-N 0.000 description 15
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 15
• 241000186660 Lactobacillus Species 0.000 description 15
• 101710198224 Ornithine carbamoyltransferase, mitochondrial Proteins 0.000 description 15
• 230000001419 dependent effect Effects 0.000 description 15
• 238000010586 diagram Methods 0.000 description 15
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 15
• 235000004554 glutamine Nutrition 0.000 description 15
• 208000024891 symptom Diseases 0.000 description 15
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 14
• RFMMMVDNIPUKGG-YFKPBYRVSA-N N-acetyl-L-glutamic acid Chemical compound CC(=O)N[C@H](C(O)=O)CCC(O)=O RFMMMVDNIPUKGG-YFKPBYRVSA-N 0.000 description 14
• 235000013922 glutamic acid Nutrition 0.000 description 14
• 239000004220 glutamic acid Substances 0.000 description 14
• 238000000338 in vitro Methods 0.000 description 14
• 229940039696 lactobacillus Drugs 0.000 description 14
• 229960003646 lysine Drugs 0.000 description 14
• 235000018977 lysine Nutrition 0.000 description 14
• 230000001404 mediated effect Effects 0.000 description 14
• 230000037361 pathway Effects 0.000 description 14
• 230000032258 transport Effects 0.000 description 14
• 101710165738 Acetylornithine aminotransferase Proteins 0.000 description 13
• 230000000694 effects Effects 0.000 description 13
• 101150026728 tesB gene Proteins 0.000 description 13
• 229930101283 tetracycline Natural products 0.000 description 13
• 102000053640 Argininosuccinate synthases Human genes 0.000 description 12
• 108700024106 Argininosuccinate synthases Proteins 0.000 description 12
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 12
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 12
• 108091023040 Transcription factor Proteins 0.000 description 12
• 102000040945 Transcription factor Human genes 0.000 description 12
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 12
• 230000004888 barrier function Effects 0.000 description 12
• 230000003115 biocidal effect Effects 0.000 description 12
• 230000006870 function Effects 0.000 description 12
• 230000002496 gastric effect Effects 0.000 description 12
• 229960002885 histidine Drugs 0.000 description 12
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 12
• 235000014304 histidine Nutrition 0.000 description 12
• 230000006698 induction Effects 0.000 description 12
• 229960004452 methionine Drugs 0.000 description 12
• 108060006633 protein kinase Proteins 0.000 description 12
• 230000028327 secretion Effects 0.000 description 12
• 229960004799 tryptophan Drugs 0.000 description 12
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 11
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 11
• 230000002068 genetic effect Effects 0.000 description 11
• 108020004999 messenger RNA Proteins 0.000 description 11
• 229930182817 methionine Natural products 0.000 description 11
• 235000006109 methionine Nutrition 0.000 description 11
• 230000004143 urea cycle Effects 0.000 description 11
• 241000370685 Arge Species 0.000 description 10
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 10
• 108020004705 Codon Proteins 0.000 description 10
• 208000023105 Huntington disease Diseases 0.000 description 10
• 108010002161 N-acetylornithine deacetylase Proteins 0.000 description 10
• 230000003213 activating effect Effects 0.000 description 10
• 229960001230 asparagine Drugs 0.000 description 10
• 235000009582 asparagine Nutrition 0.000 description 10
• 238000006243 chemical reaction Methods 0.000 description 10
• 230000002708 enhancing effect Effects 0.000 description 10
• 230000000670 limiting effect Effects 0.000 description 10
• 101710191958 Amino-acid acetyltransferase Proteins 0.000 description 9
• 102000009042 Argininosuccinate Lyase Human genes 0.000 description 9
• 206010061218 Inflammation Diseases 0.000 description 9
• 108091028043 Nucleic acid sequence Proteins 0.000 description 9
• 101100217185 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) aruC gene Proteins 0.000 description 9
• 239000012634 fragment Substances 0.000 description 9
• 108010050322 glutamate acetyltransferase Proteins 0.000 description 9
• 108020002326 glutamine synthetase Proteins 0.000 description 9
• 239000005090 green fluorescent protein Substances 0.000 description 9
• 238000001727 in vivo Methods 0.000 description 9
• 230000004054 inflammatory process Effects 0.000 description 9
• 230000002401 inhibitory effect Effects 0.000 description 9
• 210000002429 large intestine Anatomy 0.000 description 9
• 210000004379 membrane Anatomy 0.000 description 9
• 239000012528 membrane Substances 0.000 description 9
• 231100000252 nontoxic Toxicity 0.000 description 9
• 230000003000 nontoxic effect Effects 0.000 description 9
• KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 8
• 108010048816 AraC Transcription Factor Proteins 0.000 description 8
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 8
• 239000004098 Tetracycline Substances 0.000 description 8
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
• 101150094408 argI gene Proteins 0.000 description 8
• 101150014229 carA gene Proteins 0.000 description 8
• 101150070764 carB gene Proteins 0.000 description 8
• 238000001784 detoxification Methods 0.000 description 8
• 230000028709 inflammatory response Effects 0.000 description 8
• 230000004048 modification Effects 0.000 description 8
• 238000012986 modification Methods 0.000 description 8
• 229960005322 streptomycin Drugs 0.000 description 8
• 229960002180 tetracycline Drugs 0.000 description 8
• 235000019364 tetracycline Nutrition 0.000 description 8
• 150000003522 tetracyclines Chemical class 0.000 description 8
• 241000193830 Bacillus <bacterium> Species 0.000 description 7
• 101100163308 Clostridium perfringens (strain 13 / Type A) argR1 gene Proteins 0.000 description 7
• 102100031051 Cysteine and glycine-rich protein 1 Human genes 0.000 description 7
• 102100023795 Elafin Human genes 0.000 description 7
• 108010046335 Ferredoxin-NADP Reductase Proteins 0.000 description 7
• 101100295959 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) arcB gene Proteins 0.000 description 7
• 102000009661 Repressor Proteins Human genes 0.000 description 7
• 241000607142 Salmonella Species 0.000 description 7
• 101100022072 Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) lysJ gene Proteins 0.000 description 7
• 101150008194 argB gene Proteins 0.000 description 7
• 101150070427 argC gene Proteins 0.000 description 7
• 101150089042 argC2 gene Proteins 0.000 description 7
• 101150050866 argD gene Proteins 0.000 description 7
• 101150054318 argH gene Proteins 0.000 description 7
• 108091006374 cAMP receptor proteins Proteins 0.000 description 7
• 210000001072 colon Anatomy 0.000 description 7
• 108020001507 fusion proteins Proteins 0.000 description 7
• 102000037865 fusion proteins Human genes 0.000 description 7
• 102000005396 glutamine synthetase Human genes 0.000 description 7
• PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol Substances OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
• 210000004185 liver Anatomy 0.000 description 7
• 101150094164 lysY gene Proteins 0.000 description 7
• 101150039489 lysZ gene Proteins 0.000 description 7
• 239000000047 product Substances 0.000 description 7
• 101150061166 tetR gene Proteins 0.000 description 7
• 230000002103 transcriptional effect Effects 0.000 description 7
• 108700021045 Acetylglutamate kinase Proteins 0.000 description 6
• 235000014469 Bacillus subtilis Nutrition 0.000 description 6
• 101100096227 Bacteroides fragilis (strain 638R) argF' gene Proteins 0.000 description 6
• AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 6
• 240000006024 Lactobacillus plantarum Species 0.000 description 6
• 101100354186 Mycoplasma capricolum subsp. capricolum (strain California kid / ATCC 27343 / NCTC 10154) ptcA gene Proteins 0.000 description 6
• AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 6
• UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 6
• 108010034634 Repressor Proteins Proteins 0.000 description 6
• 230000004913 activation Effects 0.000 description 6
• 101150056313 argF gene Proteins 0.000 description 6
• 101150029940 argJ gene Proteins 0.000 description 6
• 210000003578 bacterial chromosome Anatomy 0.000 description 6
• 244000052616 bacterial pathogen Species 0.000 description 6
• 230000002759 chromosomal effect Effects 0.000 description 6
• 235000005911 diet Nutrition 0.000 description 6
• 230000037213 diet Effects 0.000 description 6
• 229940079593 drug Drugs 0.000 description 6
• 239000003814 drug Substances 0.000 description 6
• 239000002609 medium Substances 0.000 description 6
• 230000004060 metabolic process Effects 0.000 description 6
• 229960003104 ornithine Drugs 0.000 description 6
• 239000000758 substrate Substances 0.000 description 6
• 230000004083 survival effect Effects 0.000 description 6
• GYXHHICIFZSKKZ-UHFFFAOYSA-N 2-sulfanylacetamide Chemical compound NC(=O)CS GYXHHICIFZSKKZ-UHFFFAOYSA-N 0.000 description 5
• KDZOASGQNOPSCU-WDSKDSINSA-N Argininosuccinic acid Chemical compound OC(=O)[C@@H](N)CCC\N=C(/N)N[C@H](C(O)=O)CC(O)=O KDZOASGQNOPSCU-WDSKDSINSA-N 0.000 description 5
• 244000063299 Bacillus subtilis Species 0.000 description 5
• 241000193163 Clostridioides difficile Species 0.000 description 5
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 5
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 5
• 108700039887 Essential Genes Proteins 0.000 description 5
• 108091006228 GABA transporters Proteins 0.000 description 5
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
• 241000282412 Homo Species 0.000 description 5
• 240000001046 Lactobacillus acidophilus Species 0.000 description 5
• 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 5
• 235000013965 Lactobacillus plantarum Nutrition 0.000 description 5
• 108010076504 Protein Sorting Signals Proteins 0.000 description 5
• 241000235070 Saccharomyces Species 0.000 description 5
• 102000003929 Transaminases Human genes 0.000 description 5
• 108090000340 Transaminases Proteins 0.000 description 5
• 230000004075 alteration Effects 0.000 description 5
• FFQKYPRQEYGKAF-UHFFFAOYSA-N carbamoyl phosphate Chemical compound NC(=O)OP(O)(O)=O FFQKYPRQEYGKAF-UHFFFAOYSA-N 0.000 description 5
• 230000015556 catabolic process Effects 0.000 description 5
• 230000008859 change Effects 0.000 description 5
• 230000003247 decreasing effect Effects 0.000 description 5
• 230000002950 deficient Effects 0.000 description 5
• 238000006471 dimerization reaction Methods 0.000 description 5
• 230000000447 dimerizing effect Effects 0.000 description 5
• 239000008103 glucose Substances 0.000 description 5
• 229930195712 glutamate Natural products 0.000 description 5
• 235000008085 high protein diet Nutrition 0.000 description 5
• 239000013067 intermediate product Substances 0.000 description 5
• 210000000936 intestine Anatomy 0.000 description 5
• 229930027917 kanamycin Natural products 0.000 description 5
• 229960000318 kanamycin Drugs 0.000 description 5
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 5
• 229930182823 kanamycin A Natural products 0.000 description 5
• 229940039695 lactobacillus acidophilus Drugs 0.000 description 5
• 229940072205 lactobacillus plantarum Drugs 0.000 description 5
• 230000007246 mechanism Effects 0.000 description 5
• 125000004433 nitrogen atom Chemical group N* 0.000 description 5
• 239000008194 pharmaceutical composition Substances 0.000 description 5
• 230000008569 process Effects 0.000 description 5
• 239000011541 reaction mixture Substances 0.000 description 5
• 239000000523 sample Substances 0.000 description 5
• 238000003786 synthesis reaction Methods 0.000 description 5
• OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 5
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
• 108091000044 4-hydroxy-tetrahydrodipicolinate synthase Proteins 0.000 description 4
• 241000193749 Bacillus coagulans Species 0.000 description 4
• BHKSYEZGBQDNRW-SCGRZTRASA-N C(CCC(=O)O)(=O)O.N[C@@H](CCCNC(N)=N)C(=O)O.N[C@@H](CCCNC(N)=N)C(=O)O Chemical compound C(CCC(=O)O)(=O)O.N[C@@H](CCCNC(N)=N)C(=O)O.N[C@@H](CCCNC(N)=N)C(=O)O BHKSYEZGBQDNRW-SCGRZTRASA-N 0.000 description 4
• 108091026890 Coding region Proteins 0.000 description 4
• 241000194033 Enterococcus Species 0.000 description 4
• 206010016654 Fibrosis Diseases 0.000 description 4
• 108091026922 FnrS RNA Proteins 0.000 description 4
• 102000037078 GABA transporters Human genes 0.000 description 4
• 101001048718 Homo sapiens Elafin Proteins 0.000 description 4
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 4
• 244000199885 Lactobacillus bulgaricus Species 0.000 description 4
• 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 4
• 241000186604 Lactobacillus reuteri Species 0.000 description 4
• 102000004317 Lyases Human genes 0.000 description 4
• 108090000856 Lyases Proteins 0.000 description 4
• 102000003939 Membrane transport proteins Human genes 0.000 description 4
• 108090000301 Membrane transport proteins Proteins 0.000 description 4
• 108020004566 Transfer RNA Proteins 0.000 description 4
• 102000004357 Transferases Human genes 0.000 description 4
• 108090000992 Transferases Proteins 0.000 description 4
• 241000700605 Viruses Species 0.000 description 4
• 239000002253 acid Substances 0.000 description 4
• 229940054340 bacillus coagulans Drugs 0.000 description 4
• 230000033228 biological regulation Effects 0.000 description 4
• 239000004202 carbamide Substances 0.000 description 4
• 210000004534 cecum Anatomy 0.000 description 4
• 230000007882 cirrhosis Effects 0.000 description 4
• 208000019425 cirrhosis of liver Diseases 0.000 description 4
• 238000003776 cleavage reaction Methods 0.000 description 4
• 150000001875 compounds Chemical class 0.000 description 4
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
• 230000002550 fecal effect Effects 0.000 description 4
• 101150106794 gabP gene Proteins 0.000 description 4
• 230000009931 harmful effect Effects 0.000 description 4
• 101150032598 hisG gene Proteins 0.000 description 4
• 230000010354 integration Effects 0.000 description 4
• HCZHHEIFKROPDY-UHFFFAOYSA-N kynurenic acid Chemical compound C1=CC=C2NC(C(=O)O)=CC(=O)C2=C1 HCZHHEIFKROPDY-UHFFFAOYSA-N 0.000 description 4
• YGPSJZOEDVAXAB-UHFFFAOYSA-N kynurenine Chemical compound OC(=O)C(N)CC(=O)C1=CC=CC=C1N YGPSJZOEDVAXAB-UHFFFAOYSA-N 0.000 description 4
• 229940004208 lactobacillus bulgaricus Drugs 0.000 description 4
• 229940001882 lactobacillus reuteri Drugs 0.000 description 4
• WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 4
• 101150040895 metJ gene Proteins 0.000 description 4
• 230000037353 metabolic pathway Effects 0.000 description 4
• 230000001717 pathogenic effect Effects 0.000 description 4
• 239000002953 phosphate buffered saline Substances 0.000 description 4
• 230000027756 respiratory electron transport chain Effects 0.000 description 4
• 230000007017 scission Effects 0.000 description 4
• 210000002784 stomach Anatomy 0.000 description 4
• 230000001629 suppression Effects 0.000 description 4
• 230000008685 targeting Effects 0.000 description 4
• 101150072314 thyA gene Proteins 0.000 description 4
• 210000001519 tissue Anatomy 0.000 description 4
• 238000012546 transfer Methods 0.000 description 4
• 230000007704 transition Effects 0.000 description 4
• 229940045136 urea Drugs 0.000 description 4
• 101100427060 Bacillus spizizenii (strain ATCC 23059 / NRRL B-14472 / W23) thyA1 gene Proteins 0.000 description 3
• 101100404144 Bacillus subtilis (strain 168) nasD gene Proteins 0.000 description 3
• 241000186016 Bifidobacterium bifidum Species 0.000 description 3
• 241001608472 Bifidobacterium longum Species 0.000 description 3
• 208000014644 Brain disease Diseases 0.000 description 3
• 230000007067 DNA methylation Effects 0.000 description 3
• 108700034853 E coli TRPR Proteins 0.000 description 3
• 108010015972 Elafin Proteins 0.000 description 3
• 208000032274 Encephalopathy Diseases 0.000 description 3
• 241001646716 Escherichia coli K-12 Species 0.000 description 3
• 101100153154 Escherichia phage T5 thy gene Proteins 0.000 description 3
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
• 241000282414 Homo sapiens Species 0.000 description 3
• 244000199866 Lactobacillus casei Species 0.000 description 3
• 235000013958 Lactobacillus casei Nutrition 0.000 description 3
• 241001468157 Lactobacillus johnsonii Species 0.000 description 3
• 241000186605 Lactobacillus paracasei Species 0.000 description 3
• 241001465754 Metazoa Species 0.000 description 3
• 101100161530 Mus musculus Acsbg1 gene Proteins 0.000 description 3
• JRLGPAXAGHMNOL-LURJTMIESA-N N(2)-acetyl-L-ornithine Chemical compound CC(=O)N[C@H](C([O-])=O)CCC[NH3+] JRLGPAXAGHMNOL-LURJTMIESA-N 0.000 description 3
• 108091005804 Peptidases Proteins 0.000 description 3
• 241000605861 Prevotella Species 0.000 description 3
• 239000004365 Protease Substances 0.000 description 3
• LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 3
• 102000018120 Recombinases Human genes 0.000 description 3
• 108010091086 Recombinases Proteins 0.000 description 3
• AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
• 101100313751 Rickettsia conorii (strain ATCC VR-613 / Malish 7) thyX gene Proteins 0.000 description 3
• 108010084086 Succinate-Semialdehyde Dehydrogenase Proteins 0.000 description 3
• 102000005566 Succinate-Semialdehyde Dehydrogenase Human genes 0.000 description 3
• KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
• 206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 description 3
• 108010069584 Type III Secretion Systems Proteins 0.000 description 3
• 206010047700 Vomiting Diseases 0.000 description 3
• 230000005856 abnormality Effects 0.000 description 3
• 101150015189 aceE gene Proteins 0.000 description 3
• 101150077561 aceF gene Proteins 0.000 description 3
• 238000007792 addition Methods 0.000 description 3
• 108700003859 araC Genes Proteins 0.000 description 3
• 101150044616 araC gene Proteins 0.000 description 3
• 150000001483 arginine derivatives Chemical class 0.000 description 3
• 230000009286 beneficial effect Effects 0.000 description 3
• 229940002008 bifidobacterium bifidum Drugs 0.000 description 3
• 229940009291 bifidobacterium longum Drugs 0.000 description 3
• 230000004071 biological effect Effects 0.000 description 3
• 210000004556 brain Anatomy 0.000 description 3
• 210000004899 c-terminal region Anatomy 0.000 description 3
• MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 210000000805 cytoplasm Anatomy 0.000 description 3
• 238000011161 development Methods 0.000 description 3
• MDCUNMLZLNGCQA-HWOAGHQOSA-N elafin Chemical compound N([C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H]1C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H]2CSSC[C@H]3C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CSSC[C@H]4C(=O)N5CCC[C@H]5C(=O)NCC(=O)N[C@H](C(N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]5N(CCC5)C(=O)[C@H]5N(CCC5)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC2=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N4)C(=O)N[C@@H](CSSC1)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N3)=O)[C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(O)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)N MDCUNMLZLNGCQA-HWOAGHQOSA-N 0.000 description 3
• 230000001747 exhibiting effect Effects 0.000 description 3
• 230000003371 gabaergic effect Effects 0.000 description 3
• 231100000234 hepatic damage Toxicity 0.000 description 3
• 230000002440 hepatic effect Effects 0.000 description 3
• TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 3
• 101150095957 ilvA gene Proteins 0.000 description 3
• 230000006872 improvement Effects 0.000 description 3
• 108010067653 lactate dehydratase Proteins 0.000 description 3
• 229940017800 lactobacillus casei Drugs 0.000 description 3
• 230000003902 lesion Effects 0.000 description 3
• 230000008818 liver damage Effects 0.000 description 3
• 101150040445 lpd gene Proteins 0.000 description 3
• 101150003321 lpdA gene Proteins 0.000 description 3
• 101150007808 lpdC gene Proteins 0.000 description 3
• 208000030159 metabolic disease Diseases 0.000 description 3
• 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 3
• BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 3
• 101150044129 nirB gene Proteins 0.000 description 3
• 238000005457 optimization Methods 0.000 description 3
• KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 3
• 230000036961 partial effect Effects 0.000 description 3
• 238000003753 real-time PCR Methods 0.000 description 3
• 238000011160 research Methods 0.000 description 3
• 238000013207 serial dilution Methods 0.000 description 3
• 101150072448 thrB gene Proteins 0.000 description 3
• 101150000850 thrC gene Proteins 0.000 description 3
• 230000014616 translation Effects 0.000 description 3
• 230000008673 vomiting Effects 0.000 description 3
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
• OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 2
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
• UIUJIQZEACWQSV-UHFFFAOYSA-M 4-oxobutanoate Chemical compound [O-]C(=O)CCC=O UIUJIQZEACWQSV-UHFFFAOYSA-M 0.000 description 2
• 101100235003 Acetobacterium woodii (strain ATCC 29683 / DSM 1030 / JCM 2381 / KCTC 1655 / WB1) lctC gene Proteins 0.000 description 2
• 101100288530 Anaerotignum propionicum lcdA gene Proteins 0.000 description 2
• 101100288531 Anaerotignum propionicum lcdB gene Proteins 0.000 description 2
• 101100288532 Anaerotignum propionicum lcdC gene Proteins 0.000 description 2
• 206010003591 Ataxia Diseases 0.000 description 2
• 241000606124 Bacteroides fragilis Species 0.000 description 2
• 241000606123 Bacteroides thetaiotaomicron Species 0.000 description 2
• 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 2
• 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 2
• 206010048962 Brain oedema Diseases 0.000 description 2
• 102000014914 Carrier Proteins Human genes 0.000 description 2
• 241000423301 Clostridioides difficile 630 Species 0.000 description 2
• 101100506210 Clostridioides difficile hadC gene Proteins 0.000 description 2
• 101100506213 Clostridioides difficile hadI gene Proteins 0.000 description 2
• 241000193171 Clostridium butyricum Species 0.000 description 2
• 108700010070 Codon Usage Proteins 0.000 description 2
• 206010010071 Coma Diseases 0.000 description 2
• 206010010904 Convulsion Diseases 0.000 description 2
• 102000004127 Cytokines Human genes 0.000 description 2
• 108090000695 Cytokines Proteins 0.000 description 2
• 108010028127 Dihydrolipoamide Dehydrogenase Proteins 0.000 description 2
• 102000028526 Dihydrolipoamide Dehydrogenase Human genes 0.000 description 2
• 101150110799 ETFA gene Proteins 0.000 description 2
• 241000194031 Enterococcus faecium Species 0.000 description 2
• 101100394050 Escherichia coli (strain K12) gyrB gene Proteins 0.000 description 2
• 241000186394 Eubacterium Species 0.000 description 2
• 206010016717 Fistula Diseases 0.000 description 2
• 102000005915 GABA Receptors Human genes 0.000 description 2
• 108010005551 GABA Receptors Proteins 0.000 description 2
• 102400000326 Glucagon-like peptide 2 Human genes 0.000 description 2
• 101800000221 Glucagon-like peptide 2 Proteins 0.000 description 2
• 102100024977 Glutamine-tRNA ligase Human genes 0.000 description 2
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
• 102000003814 Interleukin-10 Human genes 0.000 description 2
• 108090000174 Interleukin-10 Proteins 0.000 description 2
• 108010066979 Interleukin-27 Proteins 0.000 description 2
• 102000004889 Interleukin-6 Human genes 0.000 description 2
• 108090001005 Interleukin-6 Proteins 0.000 description 2
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
• UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 2
• 241000218588 Lactobacillus rhamnosus Species 0.000 description 2
• YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 2
• 241000699666 Mus <mouse, genus> Species 0.000 description 2
• 102100031789 Myeloid-derived growth factor Human genes 0.000 description 2
• 206010060860 Neurological symptom Diseases 0.000 description 2
• 108091081548 Palindromic sequence Proteins 0.000 description 2
• 108010001267 Protein Subunits Proteins 0.000 description 2
• 102000002067 Protein Subunits Human genes 0.000 description 2
• 108020004511 Recombinant DNA Proteins 0.000 description 2
• 206010038664 Respiratory alkalosis Diseases 0.000 description 2
• 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
• 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
• 241001468001 Salmonella virus SP6 Species 0.000 description 2
• 101000888131 Schizosaccharomyces pombe (strain 972 / ATCC 24843) Glutamate synthase [NADH] Proteins 0.000 description 2
• 241000191940 Staphylococcus Species 0.000 description 2
• 244000057717 Streptococcus lactis Species 0.000 description 2
• 235000014897 Streptococcus lactis Nutrition 0.000 description 2
• 101100028324 Streptomyces rimosus subsp. rimosus (strain ATCC 10970 / DSM 40260 / JCM 4667 / NRRL 2234) oxyS gene Proteins 0.000 description 2
• 208000006011 Stroke Diseases 0.000 description 2
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
• 102000046299 Transforming Growth Factor beta1 Human genes 0.000 description 2
• 102000011117 Transforming Growth Factor beta2 Human genes 0.000 description 2
• 101800002279 Transforming growth factor beta-1 Proteins 0.000 description 2
• 101800000304 Transforming growth factor beta-2 Proteins 0.000 description 2
• 102000007641 Trefoil Factors Human genes 0.000 description 2
• 108010007389 Trefoil Factors Proteins 0.000 description 2
• 241000589892 Treponema denticola Species 0.000 description 2
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
• 206010047571 Visual impairment Diseases 0.000 description 2
• 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 2
• ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
• 238000006640 acetylation reaction Methods 0.000 description 2
• 101150004068 acrB gene Proteins 0.000 description 2
• 101150068316 acrC gene Proteins 0.000 description 2
• 108010041620 acryloyl-CoA reductase Proteins 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 230000001154 acute effect Effects 0.000 description 2
• HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 2
• 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 2
• WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 2
• 238000010171 animal model Methods 0.000 description 2
• KDZOASGQNOPSCU-UHFFFAOYSA-N argininosuccinate Chemical compound OC(=O)C(N)CCCN=C(N)NC(C(O)=O)CC(O)=O KDZOASGQNOPSCU-UHFFFAOYSA-N 0.000 description 2
• 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 2
• 235000003704 aspartic acid Nutrition 0.000 description 2
• 101150024707 astC gene Proteins 0.000 description 2
• 230000003305 autocrine Effects 0.000 description 2
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
• 229940004120 bifidobacterium infantis Drugs 0.000 description 2
• 229940009289 bifidobacterium lactis Drugs 0.000 description 2
• 230000001588 bifunctional effect Effects 0.000 description 2
• 230000008238 biochemical pathway Effects 0.000 description 2
• 208000006752 brain edema Diseases 0.000 description 2
• 229910002091 carbon monoxide Inorganic materials 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 238000005119 centrifugation Methods 0.000 description 2
• 230000000295 complement effect Effects 0.000 description 2
• 238000011461 current therapy Methods 0.000 description 2
• 230000034994 death Effects 0.000 description 2
• 231100000517 death Toxicity 0.000 description 2
• 238000006731 degradation reaction Methods 0.000 description 2
• BABWHSBPEIVBBZ-UHFFFAOYSA-N diazete Chemical compound C1=CN=N1 BABWHSBPEIVBBZ-UHFFFAOYSA-N 0.000 description 2
• 239000000539 dimer Substances 0.000 description 2
• 230000008030 elimination Effects 0.000 description 2
• 238000003379 elimination reaction Methods 0.000 description 2
• 210000003238 esophagus Anatomy 0.000 description 2
• 210000001723 extracellular space Anatomy 0.000 description 2
• 230000003890 fistula Effects 0.000 description 2
• 235000013305 food Nutrition 0.000 description 2
• 230000005714 functional activity Effects 0.000 description 2
• 239000007789 gas Substances 0.000 description 2
• 235000021472 generally recognized as safe Nutrition 0.000 description 2
• 210000004907 gland Anatomy 0.000 description 2
• TWSALRJGPBVBQU-PKQQPRCHSA-N glucagon-like peptide 2 Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O)[C@@H](C)CC)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)CC)C1=CC=CC=C1 TWSALRJGPBVBQU-PKQQPRCHSA-N 0.000 description 2
• 108010051239 glutaminyl-tRNA synthetase Proteins 0.000 description 2
• 229960002815 glycerol phenylbutyrate Drugs 0.000 description 2
• ZSDBFLMJVAGKOU-UHFFFAOYSA-N glycerol phenylbutyrate Chemical compound C=1C=CC=CC=1CCCC(=O)OCC(OC(=O)CCCC=1C=CC=CC=1)COC(=O)CCCC1=CC=CC=C1 ZSDBFLMJVAGKOU-UHFFFAOYSA-N 0.000 description 2
• 230000012010 growth Effects 0.000 description 2
• 239000001963 growth medium Substances 0.000 description 2
• LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 2
• 208000027700 hepatic dysfunction Diseases 0.000 description 2
• 101150063051 hom gene Proteins 0.000 description 2
• 230000002631 hypothermal effect Effects 0.000 description 2
• 230000007954 hypoxia Effects 0.000 description 2
• 230000001976 improved effect Effects 0.000 description 2
• 239000000411 inducer Substances 0.000 description 2
• 230000004968 inflammatory condition Effects 0.000 description 2
• 230000002757 inflammatory effect Effects 0.000 description 2
• 229940100601 interleukin-6 Drugs 0.000 description 2
• 230000007794 irritation Effects 0.000 description 2
• 238000011866 long-term treatment Methods 0.000 description 2
• 210000003750 lower gastrointestinal tract Anatomy 0.000 description 2
• DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 2
• 229960003987 melatonin Drugs 0.000 description 2
• 230000000813 microbial effect Effects 0.000 description 2
• 101150041177 mntH gene Proteins 0.000 description 2
• 239000000178 monomer Substances 0.000 description 2
• 210000003205 muscle Anatomy 0.000 description 2
• 210000002569 neuron Anatomy 0.000 description 2
• 239000002858 neurotransmitter agent Substances 0.000 description 2
• 210000000056 organ Anatomy 0.000 description 2
• 230000008520 organization Effects 0.000 description 2
• 230000007918 pathogenicity Effects 0.000 description 2
• 239000000546 pharmaceutical excipient Substances 0.000 description 2
• 231100000614 poison Toxicity 0.000 description 2
• 210000003240 portal vein Anatomy 0.000 description 2
• 239000002243 precursor Substances 0.000 description 2
• 235000019419 proteases Nutrition 0.000 description 2
• 230000017854 proteolysis Effects 0.000 description 2
• 108010054624 red fluorescent protein Proteins 0.000 description 2
• 238000011218 seed culture Methods 0.000 description 2
• 239000011734 sodium Substances 0.000 description 2
• 229910052708 sodium Inorganic materials 0.000 description 2
• 230000006641 stabilisation Effects 0.000 description 2
• 238000011105 stabilization Methods 0.000 description 2
• 238000003756 stirring Methods 0.000 description 2
• 230000002123 temporal effect Effects 0.000 description 2
• 101150014006 thrA gene Proteins 0.000 description 2
• 239000003440 toxic substance Substances 0.000 description 2
• 238000013519 translation Methods 0.000 description 2
• 230000005945 translocation Effects 0.000 description 2
• 101150006320 trpR gene Proteins 0.000 description 2
• 102000003390 tumor necrosis factor Human genes 0.000 description 2
• 210000002438 upper gastrointestinal tract Anatomy 0.000 description 2
• 210000002700 urine Anatomy 0.000 description 2
• 230000035899 viability Effects 0.000 description 2
• 208000029257 vision disease Diseases 0.000 description 2
• 230000004393 visual impairment Effects 0.000 description 2
• WTFXTQVDAKGDEY-UHFFFAOYSA-N (-)-chorismic acid Natural products OC1C=CC(C(O)=O)=CC1OC(=C)C(O)=O WTFXTQVDAKGDEY-UHFFFAOYSA-N 0.000 description 1
• CCWGVBYAMXWVBI-JEDNCBNOSA-N (2s)-2-acetamidopentanedioic acid;phosphoric acid Chemical compound OP(O)(O)=O.CC(=O)N[C@H](C(O)=O)CCC(O)=O CCWGVBYAMXWVBI-JEDNCBNOSA-N 0.000 description 1
• MKJIEFSOBYUXJB-HOCLYGCPSA-N (3S,11bS)-9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one Chemical compound C1CN2C[C@H](CC(C)C)C(=O)C[C@H]2C2=C1C=C(OC)C(OC)=C2 MKJIEFSOBYUXJB-HOCLYGCPSA-N 0.000 description 1
• UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
• VVJYUAYZJAKGRQ-UHFFFAOYSA-N 1-[4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C(O)C1 VVJYUAYZJAKGRQ-UHFFFAOYSA-N 0.000 description 1
• SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
• NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
• 108010055682 3-hydroxybutyryl-CoA dehydrogenase Proteins 0.000 description 1
• 108010058756 ATP phosphoribosyltransferase Proteins 0.000 description 1
• 102000005416 ATP-Binding Cassette Transporters Human genes 0.000 description 1
• 108010006533 ATP-Binding Cassette Transporters Proteins 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
• 241001430271 Acetitomaculum Species 0.000 description 1
• 241001135190 Acetohalobium Species 0.000 description 1
• 241000204396 Acetonema Species 0.000 description 1
• 208000019932 Aciduria Diseases 0.000 description 1
• 101100295756 Acinetobacter baumannii (strain ATCC 19606 / DSM 30007 / JCM 6841 / CCUG 19606 / CIP 70.34 / NBRC 109757 / NCIMB 12457 / NCTC 12156 / 81) omp38 gene Proteins 0.000 description 1
• 101710120269 Acyl-CoA thioester hydrolase YbgC Proteins 0.000 description 1
• 206010067484 Adverse reaction Diseases 0.000 description 1
• 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
• 108010082126 Alanine transaminase Proteins 0.000 description 1
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
• 101710092462 Alpha-hemolysin Proteins 0.000 description 1
• 108091093088 Amplicon Proteins 0.000 description 1
• 241001136167 Anaerotignum propionicum Species 0.000 description 1
• 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
• 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
• 108010070255 Aspartate-ammonia ligase Proteins 0.000 description 1
• 101000742087 Bacillus subtilis (strain 168) ATP-dependent threonine adenylase Proteins 0.000 description 1
• 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 1
• 108010077805 Bacterial Proteins Proteins 0.000 description 1
• 108010037058 Bacterial Secretion Systems Proteins 0.000 description 1
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
• 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
• 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
• 241000186146 Brevibacterium Species 0.000 description 1
• 108700024126 Butyrate kinases Proteins 0.000 description 1
• 108010068197 Butyryl-CoA Dehydrogenase Proteins 0.000 description 1
• 101100339117 Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168) hisF1 gene Proteins 0.000 description 1
• 241000131329 Carabidae Species 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• 102100024423 Carbonic anhydrase 9 Human genes 0.000 description 1
• 206010058892 Carnitine deficiency Diseases 0.000 description 1
• 108091006146 Channels Proteins 0.000 description 1
• 108010060434 Co-Repressor Proteins Proteins 0.000 description 1
• 102000008169 Co-Repressor Proteins Human genes 0.000 description 1
• 206010009900 Colitis ulcerative Diseases 0.000 description 1
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
• 208000011231 Crohn disease Diseases 0.000 description 1
• 241000195493 Cryptophyta Species 0.000 description 1
• 108020004414 DNA Proteins 0.000 description 1
• 238000007702 DNA assembly Methods 0.000 description 1
• 102100029133 DNA damage-induced apoptosis suppressor protein Human genes 0.000 description 1
• 206010011878 Deafness Diseases 0.000 description 1
• 101710088194 Dehydrogenase Proteins 0.000 description 1
• 108010016626 Dipeptides Proteins 0.000 description 1
• 206010013142 Disinhibition Diseases 0.000 description 1
• 208000012661 Dyskinesia Diseases 0.000 description 1
• 238000002965 ELISA Methods 0.000 description 1
• 241000588921 Enterobacteriaceae Species 0.000 description 1
• 108050000784 Ferritin Proteins 0.000 description 1
• 102000008857 Ferritin Human genes 0.000 description 1
• 238000008416 Ferritin Methods 0.000 description 1
• MBMLMWLHJBBADN-UHFFFAOYSA-N Ferrous sulfide Chemical class [Fe]=S MBMLMWLHJBBADN-UHFFFAOYSA-N 0.000 description 1
• 241000192125 Firmicutes Species 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 241000605909 Fusobacterium Species 0.000 description 1
• 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
• 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
• 108050001280 GABA permeases Proteins 0.000 description 1
• 108020004206 Gamma-glutamyltransferase Proteins 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 206010064571 Gene mutation Diseases 0.000 description 1
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
• 241000626621 Geobacillus Species 0.000 description 1
• 102000016901 Glutamate dehydrogenase Human genes 0.000 description 1
• 108010073324 Glutaminase Proteins 0.000 description 1
• 102000009127 Glutaminase Human genes 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 101100082540 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) pcp gene Proteins 0.000 description 1
• 102100029100 Hematopoietic prostaglandin D synthase Human genes 0.000 description 1
• 102100039894 Hemoglobin subunit delta Human genes 0.000 description 1
• 108010006464 Hemolysin Proteins Proteins 0.000 description 1
• 206010019663 Hepatic failure Diseases 0.000 description 1
• 101000918646 Homo sapiens DNA damage-induced apoptosis suppressor protein Proteins 0.000 description 1
• 101000988802 Homo sapiens Hematopoietic prostaglandin D synthase Proteins 0.000 description 1
• 108010064711 Homoserine dehydrogenase Proteins 0.000 description 1
• 206010021113 Hypothermia Diseases 0.000 description 1
• 102100030764 Inactive L-threonine 3-dehydrogenase, mitochondrial Human genes 0.000 description 1
• 206010062018 Inborn error of metabolism Diseases 0.000 description 1
• 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
• 108091092195 Intron Proteins 0.000 description 1
• 208000015592 Involuntary movements Diseases 0.000 description 1
• FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
• 229930182816 L-glutamine Natural products 0.000 description 1
• 229930195722 L-methionine Natural products 0.000 description 1
• 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 description 1
• 108010043075 L-threonine 3-dehydrogenase Proteins 0.000 description 1
• 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 1
• 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
• 241000589248 Legionella Species 0.000 description 1
• 208000007764 Legionnaires' Disease Diseases 0.000 description 1
• 102000001109 Leukocyte L1 Antigen Complex Human genes 0.000 description 1
• 108010069316 Leukocyte L1 Antigen Complex Proteins 0.000 description 1
• 102000004086 Ligand-Gated Ion Channels Human genes 0.000 description 1
• 108090000543 Ligand-Gated Ion Channels Proteins 0.000 description 1
• 208000035752 Live birth Diseases 0.000 description 1
• 241000604448 Megasphaera elsdenii Species 0.000 description 1
• 102000018897 Membrane Fusion Proteins Human genes 0.000 description 1
• 108010027796 Membrane Fusion Proteins Proteins 0.000 description 1
• 208000019255 Menstrual disease Diseases 0.000 description 1
• 241000162311 Moritella profunda Species 0.000 description 1
• MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
• 101001023834 Mus musculus Neutrophil gelatinase-associated lipocalin Proteins 0.000 description 1
• 101100178822 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) htrA1 gene Proteins 0.000 description 1
• 108700043217 N-acetyl glutamate synthetase deficiency Proteins 0.000 description 1
• 108010072610 N-acetyl-gamma-glutamyl-phosphate reductase Proteins 0.000 description 1
• 206010071092 N-acetylglutamate synthase deficiency Diseases 0.000 description 1
• 206010028813 Nausea Diseases 0.000 description 1
• 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
• 206010029155 Nephropathy toxic Diseases 0.000 description 1
• 108090000913 Nitrate Reductases Proteins 0.000 description 1
• 108010038807 Oligopeptides Proteins 0.000 description 1
• 102000015636 Oligopeptides Human genes 0.000 description 1
• 108090000691 Ornithine aminotransferases Proteins 0.000 description 1
• 102000004132 Ornithine aminotransferases Human genes 0.000 description 1
• 101710113020 Ornithine transcarbamylase, mitochondrial Proteins 0.000 description 1
• 101710116435 Outer membrane protein Proteins 0.000 description 1
• 241000178986 Oxobacter Species 0.000 description 1
• 101150032327 PI3 gene Proteins 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 208000018737 Parkinson disease Diseases 0.000 description 1
• 101100026007 Paulinella chromatophora ndhK gene Proteins 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108010013639 Peptidoglycan Proteins 0.000 description 1
• 241001607889 Peptoclostridium Species 0.000 description 1
• 101100124346 Photorhabdus laumondii subsp. laumondii (strain DSM 15139 / CIP 105565 / TT01) hisCD gene Proteins 0.000 description 1
• 229920001213 Polysorbate 20 Polymers 0.000 description 1
• XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
• 102000018819 Protein Translocation Systems Human genes 0.000 description 1
• 208000028017 Psychotic disease Diseases 0.000 description 1
• 101710126089 Putative inactive carbonic anhydrase 5B-like protein Proteins 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• 108700008625 Reporter Genes Proteins 0.000 description 1
• 108091027981 Response element Proteins 0.000 description 1
• 101100277437 Rhizobium meliloti (strain 1021) degP1 gene Proteins 0.000 description 1
• 235000001537 Ribes X gardonianum Nutrition 0.000 description 1
• 235000001535 Ribes X utile Nutrition 0.000 description 1
• 235000016919 Ribes petraeum Nutrition 0.000 description 1
• 244000281247 Ribes rubrum Species 0.000 description 1
• 235000002355 Ribes spicatum Nutrition 0.000 description 1
• 101100064044 Schizosaccharomyces pombe (strain 972 / ATCC 24843) pol1 gene Proteins 0.000 description 1
• 241000245026 Scoliopus bigelovii Species 0.000 description 1
• 108091058545 Secretory proteins Proteins 0.000 description 1
• 102000040739 Secretory proteins Human genes 0.000 description 1
• 206010040047 Sepsis Diseases 0.000 description 1
• 241000607768 Shigella Species 0.000 description 1
• 241000607762 Shigella flexneri Species 0.000 description 1
• 102100024639 Short-chain specific acyl-CoA dehydrogenase, mitochondrial Human genes 0.000 description 1
• 241000204388 Sporomusa Species 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 108091081024 Start codon Proteins 0.000 description 1
• 241000187433 Streptomyces clavuligerus Species 0.000 description 1
• 108700005078 Synthetic Genes Proteins 0.000 description 1
• 241001234687 Thermacetogenium Species 0.000 description 1
• 241000204652 Thermotoga Species 0.000 description 1
• 101000774739 Thermus thermophilus Aspartokinase Proteins 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• 102100033451 Thyroid hormone receptor beta Human genes 0.000 description 1
• 108091036408 Toxin-antitoxin system Proteins 0.000 description 1
• 101710081312 Trans-2-enoyl-CoA reductase Proteins 0.000 description 1
• 108700009124 Transcription Initiation Site Proteins 0.000 description 1
• 102000004338 Transferrin Human genes 0.000 description 1
• 108090000901 Transferrin Proteins 0.000 description 1
• 206010044565 Tremor Diseases 0.000 description 1
• 241000589886 Treponema Species 0.000 description 1
• 108010058153 Twin-Arginine-Translocation System Proteins 0.000 description 1
• 108010064721 Type I Secretion Systems Proteins 0.000 description 1
• 108010008681 Type II Secretion Systems Proteins 0.000 description 1
• 108010046504 Type IV Secretion Systems Proteins 0.000 description 1
• 108010046179 Type VI Secretion Systems Proteins 0.000 description 1
• 108010050970 Type VII Secretion Systems Proteins 0.000 description 1
• 201000006704 Ulcerative Colitis Diseases 0.000 description 1
• 108010046334 Urease Proteins 0.000 description 1
• 206010052428 Wound Diseases 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• 241000607734 Yersinia <bacteria> Species 0.000 description 1
• 241000607479 Yersinia pestis Species 0.000 description 1
• 238000010521 absorption reaction Methods 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 229940100228 acetyl coenzyme a Drugs 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 102000005421 acetyltransferase Human genes 0.000 description 1
• 108020002494 acetyltransferase Proteins 0.000 description 1
• 239000004480 active ingredient Substances 0.000 description 1
• 230000010933 acylation Effects 0.000 description 1
• 238000005917 acylation reaction Methods 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 230000000996 additive effect Effects 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 230000006838 adverse reaction Effects 0.000 description 1
• 230000009603 aerobic growth Effects 0.000 description 1
• 230000003281 allosteric effect Effects 0.000 description 1
• 102000013529 alpha-Fetoproteins Human genes 0.000 description 1
• 108010026331 alpha-Fetoproteins Proteins 0.000 description 1
• DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
• 229960003805 amantadine Drugs 0.000 description 1
• 230000009435 amidation Effects 0.000 description 1
• 238000007112 amidation reaction Methods 0.000 description 1
• 150000003862 amino acid derivatives Chemical class 0.000 description 1
• 125000000539 amino acid group Chemical group 0.000 description 1
• 230000037354 amino acid metabolism Effects 0.000 description 1
• 125000003277 amino group Chemical group 0.000 description 1
• 210000002255 anal canal Anatomy 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000003460 anti-nuclear Effects 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 239000000427 antigen Substances 0.000 description 1
• 108091007433 antigens Proteins 0.000 description 1
• 102000036639 antigens Human genes 0.000 description 1
• 239000000164 antipsychotic agent Substances 0.000 description 1
• 229940005529 antipsychotics Drugs 0.000 description 1
• 210000000436 anus Anatomy 0.000 description 1
• 230000004596 appetite loss Effects 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• 101150017736 araD gene Proteins 0.000 description 1
• 101150042295 arfA gene Proteins 0.000 description 1
• 210000001130 astrocyte Anatomy 0.000 description 1
• 208000025261 autosomal dominant disease Diseases 0.000 description 1
• 210000004227 basal ganglia Anatomy 0.000 description 1
• 229940049706 benzodiazepine Drugs 0.000 description 1
• 150000001557 benzodiazepines Chemical class 0.000 description 1
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
• 230000000975 bioactive effect Effects 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 230000008499 blood brain barrier function Effects 0.000 description 1
• 239000003114 blood coagulation factor Substances 0.000 description 1
• 229940019700 blood coagulation factors Drugs 0.000 description 1
• 210000001218 blood-brain barrier Anatomy 0.000 description 1
• 210000001124 body fluid Anatomy 0.000 description 1
• 239000010839 body fluid Substances 0.000 description 1
• 210000004958 brain cell Anatomy 0.000 description 1
• 230000003925 brain function Effects 0.000 description 1
• 235000012467 brownies Nutrition 0.000 description 1
• KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
• NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 1
• 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 229910052799 carbon Inorganic materials 0.000 description 1
• 239000000969 carrier Substances 0.000 description 1
• 239000003054 catalyst Substances 0.000 description 1
• 238000006555 catalytic reaction Methods 0.000 description 1
• 150000001768 cations Chemical class 0.000 description 1
• 230000030833 cell death Effects 0.000 description 1
• 230000004709 cell invasion Effects 0.000 description 1
• 210000003169 central nervous system Anatomy 0.000 description 1
• 230000002490 cerebral effect Effects 0.000 description 1
• 230000003788 cerebral perfusion Effects 0.000 description 1
• 229910052729 chemical element Inorganic materials 0.000 description 1
• 239000007795 chemical reaction product Substances 0.000 description 1
• 108091006116 chimeric peptides Proteins 0.000 description 1
• 229960005091 chloramphenicol Drugs 0.000 description 1
• WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
• WTFXTQVDAKGDEY-HTQZYQBOSA-N chorismic acid Chemical compound O[C@@H]1C=CC(C(O)=O)=C[C@H]1OC(=C)C(O)=O WTFXTQVDAKGDEY-HTQZYQBOSA-N 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 230000004087 circulation Effects 0.000 description 1
• DGBIGWXXNGSACT-UHFFFAOYSA-N clonazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl DGBIGWXXNGSACT-UHFFFAOYSA-N 0.000 description 1
• 229960003120 clonazepam Drugs 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 230000019771 cognition Effects 0.000 description 1
• 230000001149 cognitive effect Effects 0.000 description 1
• 238000009833 condensation Methods 0.000 description 1
• 230000005494 condensation Effects 0.000 description 1
• 210000002808 connective tissue Anatomy 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• 239000010949 copper Substances 0.000 description 1
• 229910052802 copper Inorganic materials 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 238000002574 cystoscopy Methods 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 231100000599 cytotoxic agent Toxicity 0.000 description 1
• 239000002619 cytotoxin Substances 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 231100000895 deafness Toxicity 0.000 description 1
• 230000007423 decrease Effects 0.000 description 1
• 230000007547 defect Effects 0.000 description 1
• 230000006735 deficit Effects 0.000 description 1
• 101150018266 degP gene Proteins 0.000 description 1
• 101150083941 degS gene Proteins 0.000 description 1
• 230000001934 delay Effects 0.000 description 1
• 238000004925 denaturation Methods 0.000 description 1
• 230000036425 denaturation Effects 0.000 description 1
• 238000001212 derivatisation Methods 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 230000000368 destabilizing effect Effects 0.000 description 1
• 230000001627 detrimental effect Effects 0.000 description 1
• 229960000633 dextran sulfate Drugs 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• 235000015872 dietary supplement Nutrition 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• 230000010339 dilation Effects 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• 208000037765 diseases and disorders Diseases 0.000 description 1
• 208000029230 disorder of organic acid metabolism Diseases 0.000 description 1
• 239000003651 drinking water Substances 0.000 description 1
• 235000020188 drinking water Nutrition 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 210000001198 duodenum Anatomy 0.000 description 1
• 230000008482 dysregulation Effects 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 239000000147 enterotoxin Substances 0.000 description 1
• 231100000655 enterotoxin Toxicity 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• 230000005713 exacerbation Effects 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 230000029142 excretion Effects 0.000 description 1
• 230000002349 favourable effect Effects 0.000 description 1
• 210000003608 fece Anatomy 0.000 description 1
• 238000011049 filling Methods 0.000 description 1
• 239000012467 final product Substances 0.000 description 1
• 210000003495 flagella Anatomy 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 238000002825 functional assay Methods 0.000 description 1
• 210000000232 gallbladder Anatomy 0.000 description 1
• 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
• 238000003304 gavage Methods 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 238000012239 gene modification Methods 0.000 description 1
• 102000034356 gene-regulatory proteins Human genes 0.000 description 1
• 108091006104 gene-regulatory proteins Proteins 0.000 description 1
• 230000005017 genetic modification Effects 0.000 description 1
• 235000013617 genetically modified food Nutrition 0.000 description 1
• 230000013595 glycosylation Effects 0.000 description 1
• 238000006206 glycosylation reaction Methods 0.000 description 1
• 101150107068 gsiB gene Proteins 0.000 description 1
• 229960003878 haloperidol Drugs 0.000 description 1
• 230000007407 health benefit Effects 0.000 description 1
• 208000016354 hearing loss disease Diseases 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 239000003228 hemolysin Substances 0.000 description 1
• 108010037896 heparin-binding hemagglutinin Proteins 0.000 description 1
• 208000006454 hepatitis Diseases 0.000 description 1
• 231100000283 hepatitis Toxicity 0.000 description 1
• 101150107671 hisB gene Proteins 0.000 description 1
• 101150113423 hisD gene Proteins 0.000 description 1
• 101150054929 hisE gene Proteins 0.000 description 1
• 101150096813 hisF gene Proteins 0.000 description 1
• 101150041745 hisI gene Proteins 0.000 description 1
• 230000003284 homeostatic effect Effects 0.000 description 1
• 108010071598 homoserine kinase Proteins 0.000 description 1
• 210000003405 ileum Anatomy 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• 230000000415 inactivating effect Effects 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 208000016245 inborn errors of metabolism Diseases 0.000 description 1
• 229910001872 inorganic gas Inorganic materials 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• 230000010226 intestinal metabolism Effects 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• 210000001630 jejunum Anatomy 0.000 description 1
• 230000002147 killing effect Effects 0.000 description 1
• 238000009533 lab test Methods 0.000 description 1
• 239000000832 lactitol Substances 0.000 description 1
• 235000010448 lactitol Nutrition 0.000 description 1
• VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
• 229960003451 lactitol Drugs 0.000 description 1
• 229960000511 lactulose Drugs 0.000 description 1
• JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
• PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
• HPHUVLMMVZITSG-ZCFIWIBFSA-N levetiracetam Chemical compound CC[C@H](C(N)=O)N1CCCC1=O HPHUVLMMVZITSG-ZCFIWIBFSA-N 0.000 description 1
• 229960004002 levetiracetam Drugs 0.000 description 1
• 229920005610 lignin Polymers 0.000 description 1
• 208000007903 liver failure Diseases 0.000 description 1
• 231100000835 liver failure Toxicity 0.000 description 1
• 230000004807 localization Effects 0.000 description 1
• 235000021266 loss of appetite Nutrition 0.000 description 1
• 208000019017 loss of appetite Diseases 0.000 description 1
• 235000020905 low-protein-diet Nutrition 0.000 description 1
• 101150074251 lpp gene Proteins 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 238000007726 management method Methods 0.000 description 1
• 238000004949 mass spectrometry Methods 0.000 description 1
• 238000013178 mathematical model Methods 0.000 description 1
• 238000010197 meta-analysis Methods 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
• 230000011987 methylation Effects 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• 244000000010 microbial pathogen Species 0.000 description 1
• 244000005706 microflora Species 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 238000010172 mouse model Methods 0.000 description 1
• 230000003387 muscular Effects 0.000 description 1
• 230000017311 musculoskeletal movement, spinal reflex action Effects 0.000 description 1
• 238000002703 mutagenesis Methods 0.000 description 1
• 231100000350 mutagenesis Toxicity 0.000 description 1
• 230000008693 nausea Effects 0.000 description 1
• 230000007694 nephrotoxicity Effects 0.000 description 1
• 231100000417 nephrotoxicity Toxicity 0.000 description 1
• 210000005036 nerve Anatomy 0.000 description 1
• 230000004770 neurodegeneration Effects 0.000 description 1
• 208000015122 neurodegenerative disease Diseases 0.000 description 1
• 230000000926 neurological effect Effects 0.000 description 1
• 235000021590 normal diet Nutrition 0.000 description 1
• 101150035558 nuoB gene Proteins 0.000 description 1
• 101150103941 nuoBCD gene Proteins 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 101150087557 omcB gene Proteins 0.000 description 1
• 101150115693 ompA gene Proteins 0.000 description 1
• 101150110245 ompC gene Proteins 0.000 description 1
• 101150073640 ompF gene Proteins 0.000 description 1
• 201000008152 organic acidemia Diseases 0.000 description 1
• 101150008884 osmY gene Proteins 0.000 description 1
• 230000036542 oxidative stress Effects 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 244000045947 parasite Species 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 238000010647 peptide synthesis reaction Methods 0.000 description 1
• 210000001322 periplasm Anatomy 0.000 description 1
• 230000003285 pharmacodynamic effect Effects 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 230000035479 physiological effects, processes and functions Effects 0.000 description 1
• 101150088264 pol gene Proteins 0.000 description 1
• 101150055096 polA gene Proteins 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 102000040430 polynucleotide Human genes 0.000 description 1
• 108091033319 polynucleotide Proteins 0.000 description 1
• 239000002157 polynucleotide Substances 0.000 description 1
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
• 229940068977 polysorbate 20 Drugs 0.000 description 1
• 235000003784 poor nutrition Nutrition 0.000 description 1
• 239000011148 porous material Substances 0.000 description 1
• 238000012910 preclinical development Methods 0.000 description 1
• 238000009101 premedication Methods 0.000 description 1
• 239000003761 preservation solution Substances 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 239000013615 primer Substances 0.000 description 1
• 238000004393 prognosis Methods 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• BHMBVRSPMRCCGG-OUTUXVNYSA-N prostaglandin D2 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](C\C=C/CCCC(O)=O)[C@@H](O)CC1=O BHMBVRSPMRCCGG-OUTUXVNYSA-N 0.000 description 1
• BHMBVRSPMRCCGG-UHFFFAOYSA-N prostaglandine D2 Natural products CCCCCC(O)C=CC1C(CC=CCCCC(O)=O)C(O)CC1=O BHMBVRSPMRCCGG-UHFFFAOYSA-N 0.000 description 1
• 230000001681 protective effect Effects 0.000 description 1
• 235000021075 protein intake Nutrition 0.000 description 1
• 238000001243 protein synthesis Methods 0.000 description 1
• 230000002797 proteolythic effect Effects 0.000 description 1
• 230000006337 proteolytic cleavage Effects 0.000 description 1
• 208000020016 psychiatric disease Diseases 0.000 description 1
• 208000033685 pterin-4 alpha-carbinolamine dehydratase 1 deficiency Diseases 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• 229960004431 quetiapine Drugs 0.000 description 1
• URKOMYMAXPYINW-UHFFFAOYSA-N quetiapine Chemical compound C1CN(CCOCCO)CCN1C1=NC2=CC=CC=C2SC2=CC=CC=C12 URKOMYMAXPYINW-UHFFFAOYSA-N 0.000 description 1
• 102000005962 receptors Human genes 0.000 description 1
• 108020003175 receptors Proteins 0.000 description 1
• 238000010188 recombinant method Methods 0.000 description 1
• 230000006798 recombination Effects 0.000 description 1
• 238000005215 recombination Methods 0.000 description 1
• 210000000664 rectum Anatomy 0.000 description 1
• 238000006268 reductive amination reaction Methods 0.000 description 1
• 230000009711 regulatory function Effects 0.000 description 1
• 230000000241 respiratory effect Effects 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 229960001534 risperidone Drugs 0.000 description 1
• RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 description 1
• 230000009291 secondary effect Effects 0.000 description 1
• 238000012163 sequencing technique Methods 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 230000035939 shock Effects 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 210000002460 smooth muscle Anatomy 0.000 description 1
• WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
• 239000004299 sodium benzoate Substances 0.000 description 1
• 235000010234 sodium benzoate Nutrition 0.000 description 1
• 229960003885 sodium benzoate Drugs 0.000 description 1
• 229960002232 sodium phenylbutyrate Drugs 0.000 description 1
• VPZRWNZGLKXFOE-UHFFFAOYSA-M sodium phenylbutyrate Chemical compound [Na+].[O-]C(=O)CCCC1=CC=CC=C1 VPZRWNZGLKXFOE-UHFFFAOYSA-M 0.000 description 1
• 239000000243 solution Substances 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 210000004500 stellate cell Anatomy 0.000 description 1
• 238000003860 storage Methods 0.000 description 1
• 239000001384 succinic acid Substances 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 230000009469 supplementation Effects 0.000 description 1
• 239000004094 surface-active agent Substances 0.000 description 1
• 230000005062 synaptic transmission Effects 0.000 description 1
• 230000001839 systemic circulation Effects 0.000 description 1
• 208000016505 systemic primary carnitine deficiency disease Diseases 0.000 description 1
• 238000012360 testing method Methods 0.000 description 1
• 229960005333 tetrabenazine Drugs 0.000 description 1
• 229960002898 threonine Drugs 0.000 description 1
• 229940104230 thymidine Drugs 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 231100000820 toxicity test Toxicity 0.000 description 1
• 229910021654 trace metal Inorganic materials 0.000 description 1
• 230000005030 transcription termination Effects 0.000 description 1
• 230000037426 transcriptional repression Effects 0.000 description 1
• 239000012581 transferrin Substances 0.000 description 1
• 238000002054 transplantation Methods 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• 230000001960 triggered effect Effects 0.000 description 1
• 241000701447 unidentified baculovirus Species 0.000 description 1
• 230000003827 upregulation Effects 0.000 description 1
• 238000011144 upstream manufacturing Methods 0.000 description 1
• 210000001635 urinary tract Anatomy 0.000 description 1
• 208000019206 urinary tract infection Diseases 0.000 description 1
• 239000013598 vector Substances 0.000 description 1
• 235000015112 vegetable and seed oil Nutrition 0.000 description 1
• 239000008158 vegetable oil Substances 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 210000003462 vein Anatomy 0.000 description 1
• 108700026220 vif Genes Proteins 0.000 description 1
• 238000005406 washing Methods 0.000 description 1
• 239000002699 waste material Substances 0.000 description 1